Search

Patricia L. Morris

Examiner (ID: 11378)

Most Active Art Unit
1625
Art Unit(s)
1612, 1203, 1201, 1209, 1625
Total Applications
3798
Issued Applications
2697
Pending Applications
142
Abandoned Applications
965

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6550270 [patent_doc_number] => 20100016605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'Process' [patent_app_type] => utility [patent_app_number] => 11/721874 [patent_app_country] => US [patent_app_date] => 2005-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3337 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016605.pdf [firstpage_image] =>[orig_patent_app_number] => 11721874 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/721874
Process Dec 14, 2005 Issued
Array ( [id] => 5596865 [patent_doc_number] => 20060160783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Novel omeprazole forms and related methods' [patent_app_type] => utility [patent_app_number] => 11/303503 [patent_app_country] => US [patent_app_date] => 2005-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8777 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160783.pdf [firstpage_image] =>[orig_patent_app_number] => 11303503 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/303503
Novel omeprazole forms and related methods Dec 14, 2005 Abandoned
Array ( [id] => 4677193 [patent_doc_number] => 20080214824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Process for the Preparation of N-(4-Piperidinyl)-N-Ethyl-Phenylacetamides from N-Boc-4-Oxopiperidine' [patent_app_type] => utility [patent_app_number] => 11/793284 [patent_app_country] => US [patent_app_date] => 2005-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2164 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20080214824.pdf [firstpage_image] =>[orig_patent_app_number] => 11793284 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/793284
Process for the preparation of N-(4-piperidinyl)-N-ethyl-phenylacetamides from N-Boc-4-oxopiperidine Dec 13, 2005 Issued
Array ( [id] => 5808402 [patent_doc_number] => 20060094757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Substantially pure cilostazol and processes for making same' [patent_app_type] => utility [patent_app_number] => 11/300864 [patent_app_country] => US [patent_app_date] => 2005-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4120 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094757.pdf [firstpage_image] =>[orig_patent_app_number] => 11300864 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/300864
Substantially pure cilostazol and processes for making same Dec 13, 2005 Issued
Array ( [id] => 5808401 [patent_doc_number] => 20060094756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Substantially pure cilostazol and processes for making same' [patent_app_type] => utility [patent_app_number] => 11/300862 [patent_app_country] => US [patent_app_date] => 2005-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4120 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094756.pdf [firstpage_image] =>[orig_patent_app_number] => 11300862 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/300862
Substantially pure cilostazol and processes for making same Dec 13, 2005 Issued
Array ( [id] => 5596945 [patent_doc_number] => 20060160863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Polymorphic and amorphous forms of 2-{3-[(E)-2-(4,6-dimethyl-pyridin-2-yl)-vinyl]-1H-indazol-6-ylamino}-N-(4-hydroxy-but-2-ynyl)benzamide' [patent_app_type] => utility [patent_app_number] => 11/300017 [patent_app_country] => US [patent_app_date] => 2005-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8128 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160863.pdf [firstpage_image] =>[orig_patent_app_number] => 11300017 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/300017
Polymorphic and amorphous forms of 2-{3-[(E)-2-(4,6-dimethyl-pyridin-2-yl)-vinyl]-1H-indazol-6-ylamino}-N-(4-hydroxy-but-2-ynyl)benzamide Dec 13, 2005 Abandoned
Array ( [id] => 4765694 [patent_doc_number] => 20080176906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Substituted Pyrrole Derivative' [patent_app_type] => utility [patent_app_number] => 11/793113 [patent_app_country] => US [patent_app_date] => 2005-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38271 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20080176906.pdf [firstpage_image] =>[orig_patent_app_number] => 11793113 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/793113
Substituted Pyrrole Derivative Dec 12, 2005 Abandoned
Array ( [id] => 5149560 [patent_doc_number] => 20070049620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Cyclic tertiary amine compound' [patent_app_type] => utility [patent_app_number] => 11/301296 [patent_app_country] => US [patent_app_date] => 2005-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62311 [patent_no_of_claims] => 96 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20070049620.pdf [firstpage_image] =>[orig_patent_app_number] => 11301296 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/301296
Cyclic tertiary amine compound Dec 11, 2005 Abandoned
Array ( [id] => 5302791 [patent_doc_number] => 20090297443 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'Labeled ALPHA4BETA2 Ligands and Methods Therefor' [patent_app_type] => utility [patent_app_number] => 11/721145 [patent_app_country] => US [patent_app_date] => 2005-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13836 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20090297443.pdf [firstpage_image] =>[orig_patent_app_number] => 11721145 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/721145
Labeled ALPHA4BETA2 ligands and methods therefor Nov 30, 2005 Issued
Array ( [id] => 5844601 [patent_doc_number] => 20060122236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Substituted biaryl-carboxylate derivatives' [patent_app_type] => utility [patent_app_number] => 11/291560 [patent_app_country] => US [patent_app_date] => 2005-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14906 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122236.pdf [firstpage_image] =>[orig_patent_app_number] => 11291560 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/291560
Substituted biaryl-carboxylate derivatives Nov 30, 2005 Abandoned
Array ( [id] => 4677190 [patent_doc_number] => 20080214821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Method of Preparing Clopidogrel and Intermediates Used Therein' [patent_app_type] => utility [patent_app_number] => 11/917794 [patent_app_country] => US [patent_app_date] => 2005-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5191 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20080214821.pdf [firstpage_image] =>[orig_patent_app_number] => 11917794 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/917794
Method of preparing clopidogrel and intermediates used therein Nov 27, 2005 Issued
Array ( [id] => 425290 [patent_doc_number] => 07271273 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-18 [patent_title] => 'Method for the preparation of citalopram' [patent_app_type] => utility [patent_app_number] => 11/285922 [patent_app_country] => US [patent_app_date] => 2005-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1941 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/271/07271273.pdf [firstpage_image] =>[orig_patent_app_number] => 11285922 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/285922
Method for the preparation of citalopram Nov 22, 2005 Issued
Array ( [id] => 8629971 [patent_doc_number] => 08362043 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-29 [patent_title] => 'Caspase inhibitors and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/284366 [patent_app_country] => US [patent_app_date] => 2005-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17499 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11284366 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/284366
Caspase inhibitors and uses thereof Nov 20, 2005 Issued
Array ( [id] => 5231389 [patent_doc_number] => 20070293497 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-20 [patent_title] => '2,3,4,6-Substituted Pyridyl Derivative Compounds Useful As Beta-Secretase Inhibitors For The Treatment Of Alzheimer\'s Disease' [patent_app_type] => utility [patent_app_number] => 11/791204 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24005 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20070293497.pdf [firstpage_image] =>[orig_patent_app_number] => 11791204 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/791204
2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease Nov 17, 2005 Issued
Array ( [id] => 5875463 [patent_doc_number] => 20060167056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Polymorphs of {5-[3-(4,6-Difluoro-1H-benzoimidazol-2-yl)-1H-indazol-5-yl)-4-methyl-pyridin-3-ylmethyl}-ethyl-amine' [patent_app_type] => utility [patent_app_number] => 11/281295 [patent_app_country] => US [patent_app_date] => 2005-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 13239 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20060167056.pdf [firstpage_image] =>[orig_patent_app_number] => 11281295 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/281295
Polymorphs of {5-[3-(4,6-Difluoro-1H-benzoimidazol-2-yl)-1H-indazol-5-yl)-4-methyl-pyridin-3-ylmethyl}-ethyl-amine Nov 15, 2005 Abandoned
Array ( [id] => 5509365 [patent_doc_number] => 20090082572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'PROCESS FOR AMORPHOUS ESOMEPRAZOLE' [patent_app_type] => utility [patent_app_number] => 11/718273 [patent_app_country] => US [patent_app_date] => 2005-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 649 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20090082572.pdf [firstpage_image] =>[orig_patent_app_number] => 11718273 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/718273
PROCESS FOR AMORPHOUS ESOMEPRAZOLE Nov 13, 2005 Abandoned
Array ( [id] => 7591128 [patent_doc_number] => 07662968 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-16 [patent_title] => 'Process for preparing lansoprazole' [patent_app_type] => utility [patent_app_number] => 11/269211 [patent_app_country] => US [patent_app_date] => 2005-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8901 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/662/07662968.pdf [firstpage_image] =>[orig_patent_app_number] => 11269211 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/269211
Process for preparing lansoprazole Nov 7, 2005 Issued
Array ( [id] => 5727768 [patent_doc_number] => 20060058529 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Method for producing 3-substituted 2-chloro-5-fluoro-pyridine or its salt' [patent_app_type] => utility [patent_app_number] => 11/265179 [patent_app_country] => US [patent_app_date] => 2005-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7676 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20060058529.pdf [firstpage_image] =>[orig_patent_app_number] => 11265179 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/265179
Method for producing 3-substituted 2-chloro-5-fluoro-pyridine or its salt Nov 2, 2005 Issued
Array ( [id] => 5614452 [patent_doc_number] => 20060116380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Novel anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/265517 [patent_app_country] => US [patent_app_date] => 2005-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12726 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20060116380.pdf [firstpage_image] =>[orig_patent_app_number] => 11265517 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/265517
Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors Nov 2, 2005 Issued
Array ( [id] => 5596943 [patent_doc_number] => 20060160861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Novel nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/262953 [patent_app_country] => US [patent_app_date] => 2005-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12050 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160861.pdf [firstpage_image] =>[orig_patent_app_number] => 11262953 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/262953
Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors Oct 31, 2005 Issued
Menu